New research at the Colorado Clinical and Translational Sciences Institute (CCTSI) aims to establish safe oral antibiotic doses for infants, potentially reducing hospital stays and improving care for newborns with infections.

Thanks to the observations of the certified athletic trainer at Standley Lake High School, Liam Graham was diagnosed with Compartment Syndrome.

Wendy Kohrt, PhD, is stepping down from her role as CCTSI's Associate Director of Resources and Services after nearly 40 years.

Read the latest news from the Colorado Clinical and Translational Sciences Institute (CCTSI).

CU Anschutz gathered to consider how, as Chancellor Don Elliman said, to unlock the promise of AI while at the same time minimizing the potential dangers.

Research at CCTSI advances new CF drug, ALYFTREK, improving treatment and survival rates for children with cystic fibrosis.

CU Professor and CCTSI Program Director Anne Libby teaches researchers essential grant management and leadership skills through accessible online courses.

Learn about ethical challenges and benefits of decentralized clinical trials discussed at the 14th Annual CCTSI Research Ethics Conference.

Researcher Minghua Tang is developing evidence-based infant feeding guidelines to address gaps in current dietary recommendations for babies under 2.

A CU Department of Medicine exercise physiologist has a major NIH grant to study why older men and women get different health benefits from exercise.

Machine Learning Could Help Reduce Hospitalizations by Nearly 30 Percent During a Pandemic, Study Finds

Artificial intelligence (AI) transforms how medical professionals diagnose and treat patients, leading to advancements in research and patient outcomes.

At the CCTSI CU-CSU Summit, Jayashree Kalpathy-Cramer, PhD, addressed AI's potential in healthcare and gave an assessment of the technology’s limitations.

A CU program reviews research grant applications in advance, helping researchers improve their applications and better their chances of getting funded.

Largest Study of its Kind Finds Common Lab Tests Aren’t Reliable for Diagnosing Long COVID

Learn how a CCTSI Pilot Grant is helping students at Morgridge Academy, on the National Jewish Health campus, to better manage their asthma.

Alison Xie, of the CU Department of Surgery, received a grant to study how glial cells in the peripheral nervous system affect bladder function.

Department of Surgery members Eden Nohra and Jessica Rove Join Clinical Faculty Scholars Program to advance research careers through mentorship.

Two professors from Brazil visited the CU Anschutz Medical Campus to exchange ideas on how to enhance research, clinical care, and mentorship.

The CCTSI is pleased to announce that, starting July 1, 2024, William Cornwell, MD will serve as associate medical director of the Adult CTRC.

Jayashree Kalpathy-Cramer, PhD has joined the leadership of the Colorado Clinical and Translational Sciences Institute (CCTSI) as Director of Health Informatics.

Grow your research career with the Colorado Clinical and Translational Sciences Institute (CCTSI)!

CCTSI announces three new leaders in clinical research.

Janine Higgins, PhD, hopes the device will give people more options to control how they lose weight and approach eating.

The CU Anschutz Medical Campus hosted its third annual Research Awards ceremony to recognize the accomplishments of the campus research community.

Ronald J. Sokol, MD has been named a University of Colorado Distinguished Professor.

Health care providers, CCTSI researchers and patient advocates gathered for a roundtable discussion on Long COVID care with Colorado's Lt. Governor.

Colorado Clinical and Translational Sciences Institute (CCTSI) gathered researchers to learn about Dissemination and Implementation science.

NIH has granted $54 million to the Colorado Clinical and Translational Sciences Institute (CCTSI) to turn discoveries into better health.

CCTSI researchers from Denver Health are conducting an innovative, comprehensive systems-level intervention for individuals with methamphetamine addiction.

iHeard Colorado, a CCTSI initiative, will gather data on health topics Coloradans are talking about and then provide trusted and clear information.

Large study involving CU Anschutz researchers provides scientists with deeper insight into long COVID

This month, Barbara Hammack, PhD is retiring after dedicating 23 years to clinical research, most of which took place at the Colorado Clinical and Translational Sciences Institute.

The CU School of Medicine celebrated Rare Disease Day with an event that explored a vision for creating a regional rare disease hub.

CCTSI researchers publish in Lancet Infectious Diseases, finding that Paxlovid is effective against Omicron variants B.4 and B.5.

Colorado Clinical and Translational Sciences Institute (CCTSI) and its researchers made an impact in science across disciplines in 2022.

Colorado Clinical and Translational Sciences Institute (CCTSI) researchers have shed light on the role of inflammation in primary ciliary dyskinesia (PCD).

CU Anschutz is helping to solve the problem of a lack of diversity by training Older Adult Research Specialists (OARS). OARS help to educate and recruit other adults over 50 who may want to participate in clinical studies. Colorado Clinical and Translational Sciences Institute (CCTSI).

Two years ago, many of us had never worked from home.

Colorado Clinical and Translational Sciences Institute members from across the state recently gathered at CU Anschutz to address equitable healthcare.

CU Anschutz researchers and providers share how science informs improved alcohol use recovery tools during September’s National Recovery Month.

CCTSI's Melissa Haendel and her team of data scientists are making headlines and advising the White House while unlocking the mysteries of long COVID.

Pediatric oncologist and researcher Dr. Mike Verneris exemplifies this mission through his work with the Consortium for Pediatric Cellular Immunotherapy (CPCI).

One way the National Institutes of Health is addressing the infodemic is through a nationwide initiative called the Community Engagement Alliance against COVID-19 Disparities or CEAL.

A new study confirms ivacaftor's impact on inflammation in people with cystic fibrosis (CF). Ivacaftor targets the defective protein that causes CF.

CU Anschutz and Children’s Hospital Colorado lead national pandemic response project

The Colorado Clinical and Translational Sciences Institute (CCTSI) is pleased to announce that Matthew DeCamp, MD, PhD, will assume the role as the new leader of its research ethics program.

Since 2010, Dr. Coors has served as director of research ethics in the Colorado Clinical and Translational Sciences Institute (CCTSI).

Scientists’ discovery is one step closer to more effective COVID-19 treatment with immune modulatory drugs

Pietro the tortoise can predict when it’s about to rain. Conner Jackson set out to investigate this claim in his award-winning article.